Education/CredentialsFellowship: Albert Einstein Medical Center (Gastroenterology & Hepatology)Residency: Albert Einstein Medical Center (Internal Medicine)Medical Degree: Lady Hardinge Medical College and Associated Hospitals, University of New Delhi Board Certifications & LicensesAmerican Board of Internal Medicine (Gastroenterology) (Certification Date: 2010-10-14) - (Recertification Date: 2020-11-05) SpecialtiesDigestive DiseasesInternal Medicine Contact Information Medical Sciences Building Office 513-558-5244 Email wadhwana@ucmail.uc.edu Clinical Interests Eosinophilic EsophagitisGastroenterologyAchalasiaAcid refluxEsophageal SpasmsEsophageal Stenosis Peer Reviewed Publications Hariharan, S; Pollak, V E; Kant, K S; Weiss, M A; Wadhwa, N K 1990. Diffuse proliferative lupus nephritis: long-term observations in patients treated with ancrod. Clinical nephrology, 34 2, 61-9Pollak, V E; Glas-Greenwalt, P; Olinger, C P; Wadhwa, N K; Myre, S A 1990. Ancrod causes rapid thrombolysis in patients with acute stroke. The American journal of the medical sciences, 299 5, 319-25Clardy, C W; Schroeder, T J; Myre, S A; Wadhwa, N K; Pesce, A J; First, M R; McEnery, P T; Balistreri, W F; Harris, R E; Melvin, D B 1988. Clinical variability of cyclosporine pharmacokinetics in adult and pediatric patients after renal, cardiac, hepatic, and bone-marrow transplants. Clinical chemistry, 34 10, 2012-5Kim, S; Wadhwa, N K; Kant, K S; Pollak, V E; Glas-Greenwalt, P; Weiss, M A; Hong, C G 1988. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects. The Quarterly journal of medicine, 69 259, 879-905Munda, R; Schroeder, T J; Pedersen, S A; Clardy, C W; Wadhwa, N K; Myre, S A; Stephens, G W; Pesce, A J; Alexander, J W; First, M R 1988. Cyclosporine pharmacokinetics in pancreas transplant recipients. Transplantation proceedings, 20 2 Suppl 2, 487-90Myre, S A; Schroeder, T J; Melvin, D B; Clardy, C W; Pesce, A J; Wadhwa, N K; Collins, J A; Wolf, R K; Brown, L L; Stephens, G W 1988. Use of cyclosporine by constant-rate intravenous infusion immediately after heart transplantation. Transplantation proceedings, 20 3 Suppl 3, 316-22Wadhwa, N K; Schroeder, T J; Pesce, A J; Myre, S A; Clardy, C W; First, M R 1987. Cyclosporine drug interactions: a review. Therapeutic drug monitoring, 9 4, 399-406
Clinical Interests Eosinophilic EsophagitisGastroenterologyAchalasiaAcid refluxEsophageal SpasmsEsophageal Stenosis
Peer Reviewed Publications Hariharan, S; Pollak, V E; Kant, K S; Weiss, M A; Wadhwa, N K 1990. Diffuse proliferative lupus nephritis: long-term observations in patients treated with ancrod. Clinical nephrology, 34 2, 61-9Pollak, V E; Glas-Greenwalt, P; Olinger, C P; Wadhwa, N K; Myre, S A 1990. Ancrod causes rapid thrombolysis in patients with acute stroke. The American journal of the medical sciences, 299 5, 319-25Clardy, C W; Schroeder, T J; Myre, S A; Wadhwa, N K; Pesce, A J; First, M R; McEnery, P T; Balistreri, W F; Harris, R E; Melvin, D B 1988. Clinical variability of cyclosporine pharmacokinetics in adult and pediatric patients after renal, cardiac, hepatic, and bone-marrow transplants. Clinical chemistry, 34 10, 2012-5Kim, S; Wadhwa, N K; Kant, K S; Pollak, V E; Glas-Greenwalt, P; Weiss, M A; Hong, C G 1988. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects. The Quarterly journal of medicine, 69 259, 879-905Munda, R; Schroeder, T J; Pedersen, S A; Clardy, C W; Wadhwa, N K; Myre, S A; Stephens, G W; Pesce, A J; Alexander, J W; First, M R 1988. Cyclosporine pharmacokinetics in pancreas transplant recipients. Transplantation proceedings, 20 2 Suppl 2, 487-90Myre, S A; Schroeder, T J; Melvin, D B; Clardy, C W; Pesce, A J; Wadhwa, N K; Collins, J A; Wolf, R K; Brown, L L; Stephens, G W 1988. Use of cyclosporine by constant-rate intravenous infusion immediately after heart transplantation. Transplantation proceedings, 20 3 Suppl 3, 316-22Wadhwa, N K; Schroeder, T J; Pesce, A J; Myre, S A; Clardy, C W; First, M R 1987. Cyclosporine drug interactions: a review. Therapeutic drug monitoring, 9 4, 399-406
Hariharan, S; Pollak, V E; Kant, K S; Weiss, M A; Wadhwa, N K 1990. Diffuse proliferative lupus nephritis: long-term observations in patients treated with ancrod. Clinical nephrology, 34 2, 61-9Pollak, V E; Glas-Greenwalt, P; Olinger, C P; Wadhwa, N K; Myre, S A 1990. Ancrod causes rapid thrombolysis in patients with acute stroke. The American journal of the medical sciences, 299 5, 319-25Clardy, C W; Schroeder, T J; Myre, S A; Wadhwa, N K; Pesce, A J; First, M R; McEnery, P T; Balistreri, W F; Harris, R E; Melvin, D B 1988. Clinical variability of cyclosporine pharmacokinetics in adult and pediatric patients after renal, cardiac, hepatic, and bone-marrow transplants. Clinical chemistry, 34 10, 2012-5Kim, S; Wadhwa, N K; Kant, K S; Pollak, V E; Glas-Greenwalt, P; Weiss, M A; Hong, C G 1988. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects. The Quarterly journal of medicine, 69 259, 879-905Munda, R; Schroeder, T J; Pedersen, S A; Clardy, C W; Wadhwa, N K; Myre, S A; Stephens, G W; Pesce, A J; Alexander, J W; First, M R 1988. Cyclosporine pharmacokinetics in pancreas transplant recipients. Transplantation proceedings, 20 2 Suppl 2, 487-90Myre, S A; Schroeder, T J; Melvin, D B; Clardy, C W; Pesce, A J; Wadhwa, N K; Collins, J A; Wolf, R K; Brown, L L; Stephens, G W 1988. Use of cyclosporine by constant-rate intravenous infusion immediately after heart transplantation. Transplantation proceedings, 20 3 Suppl 3, 316-22Wadhwa, N K; Schroeder, T J; Pesce, A J; Myre, S A; Clardy, C W; First, M R 1987. Cyclosporine drug interactions: a review. Therapeutic drug monitoring, 9 4, 399-406